(June 5, 2018, 2:13 PM EDT) -- GREENVILLE, S.C. — A South Carolina federal judge on May 31 dismissed a generic Imitrex case, saying the plaintiff’s warning and design defect claims are clearly preempted by U.S. Supreme Court rulings (Jennifer Galloway v. Aurobindo Pharma Limited Inc., et al., No. 17-1076, D. S.C., Greenville Div., 2018 U.S. Dist. LEXIS 90494)....